OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Skin cancer, including related pathways and therapy and the role of luteolin derivatives as potential therapeutics
Aleksandra Maria Juszczak, Ute Wöelfle, Marijana Zovko Končić, et al.
Medicinal Research Reviews (2022) Vol. 42, Iss. 4, pp. 1423-1462
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Aggregation-induced emission photosensitizer-based photodynamic therapy in cancer: from chemical to clinical
Zijuan Meng, Huiying Xue, Tingting Wang, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 76

Flavonoids as Promising Natural Compounds in the Prevention and Treatment of Selected Skin Diseases
Beáta Čižmárová, Beáta Hubková, Vladimı́ra Tomečková, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6324-6324
Open Access | Times Cited: 52

Comprehensive overview of Nrf2-related epigenetic regulations involved in ischemia-reperfusion injury
Jun Zhang, Wanqian Pan, Yue Zhang, et al.
Theranostics (2022) Vol. 12, Iss. 15, pp. 6626-6645
Open Access | Times Cited: 40

Luteolin Attenuates Hypertension via Inhibiting NF-κB-Mediated Inflammation and PI3K/Akt Signaling Pathway in the Hypothalamic Paraventricular Nucleus
Hong‐Li Gao, Xiao‐Jing Yu, Yu‐Qi Feng, et al.
Nutrients (2023) Vol. 15, Iss. 3, pp. 502-502
Open Access | Times Cited: 22

Luteolin as a potential therapeutic candidate for lung cancer: Emerging preclinical evidence
Jin Zhang, Yue Ma
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116909-116909
Open Access | Times Cited: 7

Discovery of Novel PARP1 Inhibitors through Computational Drug Design Approaches
Md. Shamim, Md Sumon Ali, Md. Arju Hossain, et al.
Computational Biology and Chemistry (2025), pp. 108366-108366
Closed Access

Application of Polyphenols and Flavonoids in Oncological Therapy
Szymon Roszkowski
Molecules (2023) Vol. 28, Iss. 10, pp. 4080-4080
Open Access | Times Cited: 18

Luteolin-Loaded Nanoparticles for the Treatment of Melanoma
Qiao-Ting Fu, Xiaoqin Zhong, Mei‐Yu Chen, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 2053-2068
Open Access | Times Cited: 15

ALDH2 is a novel biomarker and exerts an inhibitory effect on melanoma
Lei Hua, Jinfeng Liao, Xinyu Wang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3

Luteolin binds Src, promotes STAT3 protein ubiquitination and exerts anti-melanoma effects in cell and mouse models
Ting Li, Xiu‐Qiong Fu, Bin Liu, et al.
Biochemical Pharmacology (2022) Vol. 200, pp. 115044-115044
Closed Access | Times Cited: 19

Nano-scale drug delivery systems for luteolin: advancements and applications
Jinlu Shang, Jinglei Yang, Qinmin Deng, et al.
Journal of Materials Chemistry B (2023) Vol. 11, Iss. 47, pp. 11198-11216
Closed Access | Times Cited: 9

Recent Updates Regarding the Antiproliferative Activity of Galium verum Extracts on A375 Human Malignant Melanoma Cell Line
Alexandra-Denisa Semenescu, Elena-Alina Moacă, Andrada Iftode, et al.
Life (2024) Vol. 14, Iss. 1, pp. 112-112
Open Access | Times Cited: 2

Phytochemical evaluation and exploration of some biological activities of aqueous and ethanolic extracts of two species of the genus Plantago L.
A. Bouali, Ylenia Spissu, Antonio Barberis, et al.
PLoS ONE (2024) Vol. 19, Iss. 2, pp. e0298518-e0298518
Open Access | Times Cited: 2

Semi-supervised skin cancer diagnosis based on self-feedback threshold focal learning
Weicheng Yuan, Zeyu Du, Shuo Han
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2

Controlled release, chitosan-tethered luteolin phytocubosomes; Formulation optimization to in-vivo antiglaucoma and anti-inflammatory ocular evaluation
Sarah Omran, Yosra S.R. Elnaggar, Ossama Y. Abdallah
International Journal of Biological Macromolecules (2023) Vol. 254, pp. 127930-127930
Closed Access | Times Cited: 7

Glycerol and Natural Deep Eutectic Solvents Extraction for Preparation of Luteolin-Rich Jasione montana Extracts with Cosmeceutical Activity
Aleksandra Maria Juszczak, Marijan Marijan, Lejsa Jakupović, et al.
Metabolites (2022) Vol. 13, Iss. 1, pp. 32-32
Open Access | Times Cited: 10

Multimodal Analysis of Unbalanced Dermatological Data for Skin Cancer Recognition
Pavel Lyakhov, Ulyana A. Lyakhova, Diana I. Kalita
IEEE Access (2023) Vol. 11, pp. 131487-131507
Open Access | Times Cited: 5

Exploring Herbal Remedies For Skin Cancer: A Comprehensive Review
Piyushkumar Sadhu, Falguni Rathod, Mamta Kumari, et al.
Journal Of Advanced Zoology (2024)
Open Access | Times Cited: 1

Decoding the synergistic potential of MAZ‐51 and zingerone as therapy for melanoma treatment in alignment with sustainable development goals
Kganya Letsoalo, Evangeline Nortjé, Sean Patrick, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 2
Open Access | Times Cited: 1

Evodiamine encapsulated by hyaluronic acid modified zeolitic imidazolate framework-8 for tumor targeted therapy
Qiang Zhou, Dandan Xie, Kui Wang, et al.
Drug Delivery and Translational Research (2024)
Closed Access | Times Cited: 1

Lipidomics revealed alterations in glycerophospholipid metabolism in skin squamous cell carcinoma
Lihong Mei, Hui-Hui Gan, Hongfeng Wang, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access | Times Cited: 1

Carrageenan tethered ion sensitive smart nanogel containing oleophytocubosomes for improved ocular luteolin delivery
Sarah Omran, Yosra S.R. Elnaggar, Ossama Y. Abdallah
International Journal of Pharmaceutics (2023) Vol. 646, pp. 123482-123482
Closed Access | Times Cited: 3

Luteolin overcomes acquired resistance to osimertinib in non-small cell lung cancer cells by targeting the HGF-MET-Akt pathway.
Guodong Huang, Xinning Liu, Ting Jiang, et al.
PubMed (2023) Vol. 13, Iss. 9, pp. 4145-4162
Closed Access | Times Cited: 3

Page 1 - Next Page

Scroll to top